Cancer
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
Cardiovascular
March 22, 2023
Cancer
March 20, 2023
Research
March 18, 2023
Healthcare Delivery
March 13, 2023
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community